Envestnet Asset Management Inc Synlogic, Inc. Transaction History

Envestnet Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.42 - $0.68 $5,305 - $8,589	12,631 Added 14.27%	101,170 $43,000
Q1 2023 May 11, 2023	BUY	$0.56 - $1.07 $5,526 - $10,558	9,868 Added 12.54%	88,539 $55,000
Q4 2022 Feb 07, 2023	BUY	$0.58 - $17.99 $33,410 - $1.04 Million	57,604 Added 273.43%	78,671 $59,000
Q3 2022 Nov 10, 2022	BUY	$0.91 - $14.63 $5,732 - $92,154	6,299 Added 42.65%	21,067 $20,000
Q2 2022 Aug 03, 2022	BUY	$0.89 - $2.47 $1,034 - $2,870	1,162 Added 8.54%	14,768 $17,000
Q1 2022 May 04, 2022	SELL	$1.63 - $2.55 $4,034 - $6,311	-2,475 Reduced 15.39%	13,606 $33,000
Q4 2021 Feb 04, 2022	BUY	$2.27 - $3.0 $2,190 - $2,895	965 Added 6.38%	16,081 $39,000
Q3 2021 Oct 07, 2021	BUY	$2.45 - $4.1 $37,034 - $61,975	15,116 New	15,116 $46,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.